---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-010536"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2025-05-15T23:59:59+00:00"
generated_at: "2026-05-21T05:10:40.460300+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# PAVmed Q1 GAAP net income $17.7M, adjusted loss $0.9M; Lucid raises $30.6M, cash >$40M

## Summary
- GAAP net income attributable to common stockholders $17.7M ($0.34 diluted EPS); non-GAAP adjusted loss $0.9M ($0.07 per share).
- Lucid Diagnostics (LUCD) recognized $0.8M EsoGuard revenue, processed 3,034 tests; raised $30.6M net from stock offerings, ended Q1 with over $40M pro forma cash.
- Veris Health completed financing, resumed development of implantable monitor; completed pilot with Ohio State's James Cancer Hospital, planning commercial partnership.
- PAVmed cash and cash equivalents $2.7M at March 31, 2025, up from $1.2M at Dec 31, 2024; operating expenses $5.5M including $1.0M stock-based comp.
- PAVmed seeking to expand into biopharma, evaluating clinical and late preclinical-stage assets for new subsidiary.

## SEC filing metadata
- accession: 0001641172-25-010536
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2025-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000164117225010536/0001641172-25-010536-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000164117225010536/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-010536
- JSON: https://secwatch.observer/filing/0001641172-25-010536.json
- Plain text: https://secwatch.observer/filing/0001641172-25-010536.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.